These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 125641)

  • 21. Nephrotic syndrome in procainamide induced lupus nephritis.
    Zech P; Colon S; Labeeuw M; Bernheim J; Blanc-Brunat N
    Clin Nephrol; 1979 Apr; 11(4):218-21. PubMed ID: 455820
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hydralazine and lupus nephritis.
    Ihle BU; Whitworth JA; Dowling JP; Kincaid-Smith P
    Clin Nephrol; 1984 Nov; 22(5):230-8. PubMed ID: 6240359
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Drug-induced disorders of lupus erythematosus type (author's transl)].
    Schwarz JA
    Arzneimittelforschung; 1977; 27(96):1856-64. PubMed ID: 579152
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mesangial electron-dense deposits in membranous nephropathy.
    Honig C; Mouradian JA; Montoliu J; Susin M; Sherman RL
    Lab Invest; 1980 Apr; 42(4):427-32. PubMed ID: 6445444
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Silent lupus nephritis among patients with discoid lupus erythematosus.
    Roujeau JC; Belghiti D; Hirbec G; Poli F; Sobel AT; Revuz J; Touraine R
    Acta Derm Venereol; 1984; 64(2):160-3. PubMed ID: 6203307
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Lupus nephritis: clinicomorphological manifestations (author's transl)].
    Torras A; Vallés M; Darnell A; Mirapeix E; Revert L
    Med Clin (Barc); 1980 Jun; 75(1):1-9. PubMed ID: 7392705
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [New approaches to characterizing the immune status of patients with lupus erythematosus using immunoenzyme testing].
    Glavinskaia TA; Rezaĭkina AV; Komarova VD
    Vestn Dermatol Venerol; 1990; (1):4-8. PubMed ID: 2327169
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Pseudolupus induced by a vasculotropic drug (author's transl)].
    Guardia J; Richart C; Martinez Vàzquez JM; Martin C
    Nouv Presse Med; 1977 Oct; 6(32):2873-5. PubMed ID: 917804
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Solubilization of intraglomerular deposits of IgG immune complexes by human sera or gamma-globulin in patients with lupus nephritis.
    Tomino Y; Sakai H; Takaya M; Miura M; Suga T; Endoh M; Nomoto Y
    Clin Exp Immunol; 1984 Oct; 58(1):42-8. PubMed ID: 6206971
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Deposits of immunoglobulins and C3 in the walls of human renal arteries.
    Mekori YA; Steiner P; Farkash R; Moalem T; Klajman A
    Clin Exp Immunol; 1981 Feb; 43(2):254-9. PubMed ID: 6456092
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Seronegative systemic lupus erythematosus (author's transl)].
    Goff PL; Youinou P; Le Menn G
    Sem Hop; 1981 Jun 18-25; 57(25-28):1217-20. PubMed ID: 6266042
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The characteristics of kidney involvement in a female patient with systemic lupus erythematosus and the antiphospholipid syndrome].
    Kozlovskaia NL; Kabaenkova GS; Varshavskiĭ VA; Shvetsov MIu
    Klin Med (Mosk); 1995; 73(3):93-6. PubMed ID: 8577127
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Symposium on renal involvement in systemic diseases. III. Lupus erythematosus. (2) Pathogenesis and treatment of lupus nephritis (author's transl)].
    Narita M; Koyama A
    Nihon Naika Gakkai Zasshi; 1979 Oct; 68(10):1254-8. PubMed ID: 533799
    [No Abstract]   [Full Text] [Related]  

  • 34. Clinical usefulness of the morphological classification of lupus nephritis.
    Baldwin DS
    Am J Kidney Dis; 1982 Jul; 2(1 Suppl 1):142-9. PubMed ID: 7102664
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Glomerular deposition of renal tubular epithelial antigen in patients with systemic lupus erythematosus: its possible role in lupus nephritis.
    Gilboa N; Durante D; McIntosh RM
    J Rheumatol; 1977; 4(4):358-68. PubMed ID: 604475
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Detection of circulating antibodies in the blood and immune complex precipitates of patients with autoimmune diseases (preliminary report)].
    Kiss M; Husz S; Dobozy A
    Orv Hetil; 1992 May; 133(18):1103-4, 1109-10. PubMed ID: 1579350
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cutaneous lupus erythematosus: issues in diagnosis and treatment.
    Walling HW; Sontheimer RD
    Am J Clin Dermatol; 2009; 10(6):365-81. PubMed ID: 19824738
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Humoral and cellular phenomena after intake of Venopyronum-dragées (pseudo-LE-syndrome)].
    Schwarz JA; Jost H; Simon A; Hagenthau C; Hufnagl HD; Keller HE
    Verh Dtsch Ges Inn Med; 1976; 82 Pt 2():1829-33. PubMed ID: 1030118
    [No Abstract]   [Full Text] [Related]  

  • 39. Evidence for an immune complex disorder in systemic lupus erythematosus (SLE).
    McCluskey RT
    Am J Kidney Dis; 1982 Jul; 2(1 Suppl 1):119-25. PubMed ID: 6213147
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Drug-induced lupus erythematosus.
    Vedove CD; Del Giglio M; Schena D; Girolomoni G
    Arch Dermatol Res; 2009 Jan; 301(1):99-105. PubMed ID: 18797892
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.